In Vivo Clinical and Radiological Effects of Platelet-rich Plasma on Interstitial Supraspinatus Lesion: Randomized Study
Launched by LA TOUR HOSPITAL · Feb 2, 2016
Trial Information
Current as of April 27, 2025
Unknown status
Keywords
ClinConnect Summary
DETAILLED PLANNED STATISTICAL METHODS
Hypothesis
Null hypothesis: In patients with interstitial rotator cuff tear, there is no difference in term of tendon tear size percentage between baseline and 6 months after intervention.
Alternative hypothesis: In patients with interstitial rotator cuff tear, there is a difference in term of tendon of tendon tear size percentage between baseline and 6 months after intervention.
Determination of Sample Size
No previous data allows predicting the standard deviation of supraspinatus tear volume. In order to evaluate the standard deviation of tear si...
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • Informed Consent as documented by signature (Appendix Informed Consent Form),
- • Symptomatic interstitial tear of the supraspinatus tendon,
- Exclusion Criteria:
- • Tear of infraspinatus or subscapularis tendons (same shoulder)
- • Frozen shoulder (antepulsion deficit \> 20%)
- • Corticosteroid shoulder infiltration in the 3 months prior the inclusion,
- • Patients suffering from symptomatic anaemia, or patients with severe cardiorespiratory insufficiency,
- • Known or suspected non-compliance, drug or alcohol abuse,
- • Patients incapable of judgement or under tutelage,
- • Inability to follow the procedures of the study, e.g. due to language problems, psychological disorders, dementia, etc. of the participant,
- • Previous enrolment into the current study,
- • Enrolment of the investigator, his/her family members, employees and other dependent persons,
About La Tour Hospital
La Tour Hospital is a leading healthcare institution dedicated to advancing medical research and patient care through innovative clinical trials. With a commitment to excellence, the hospital offers state-of-the-art facilities and a multidisciplinary team of experienced professionals who collaborate to ensure the highest standards of safety and efficacy in research. La Tour Hospital actively engages in a diverse range of clinical studies across various therapeutic areas, aiming to contribute valuable insights that enhance treatment options and improve patient outcomes. Its focus on ethical practices and regulatory compliance reinforces its reputation as a trusted sponsor in the clinical research community.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Meyrin, Geneva, Switzerland
Patients applied
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported
Similar Trials